Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.65 |
| ▸ | APAF1 | O14727 | 1/20 | 0.65 |
| ▸ | NPC1 | O15118 | 1/20 | 0.65 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | HTT | P42858 | 1/20 | 0.65 |
| ▸ | RAB9A | P51151 | 1/20 | 0.65 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.65 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.65 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.44 |
| ▸ | FDPS | P14324 | 11/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL318764 | 0.99 | MEN1 (0.68) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Trifluoromethanesulfonic Acid SCHEMBL514445 | 0.99 | MEN1 (0.68) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Trifluoromethanesulfonic Acid SCHEMBL1331129 | 0.99 | MEN1 (0.68) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Trifluoromethanesulfonic Acid SCHEMBL318767 | 0.99 | MEN1 (0.68) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Trifluoromethanesulfonic Acid SCHEMBL318175 | 0.99 | MEN1 (0.68) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Trifluoromethanesulfonic Acid SCHEMBL318566 | 0.99 | MEN1 (0.68) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Trifluoromethanesulfonic Acid SCHEMBL294105 | 0.96 | MEN1 (0.58) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Trifluoromethanesulfonic Acid SCHEMBL29390371 | 0.96 | MEN1 (0.58) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Trifluoromethanesulfonic Acid SCHEMBL1293510 | 0.95 | MEN1 (0.62) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Trifluoromethanesulfonic Acid SCHEMBL318471 | 0.91 | MEN1 (0.52) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210395906-A1 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | CUSTOMARRAY INC (US) | 2021-12-23 | — | — | US | claimed |
| US-20130341561-A1 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | CUSTOMARRAY, INC. (US) | 2013-12-26 | — | — | US | claimed |
| US-7718579-B2 | Electrochemical deblocking using a hydrazine derivative | COMBIMATRIX CORPORATION (US) | 2010-05-18 | — | — | US | claimed |
| EP-1869061-A2 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | Combimatrix Corporation (US) | 2007-12-26 | — | — | EP | claimed |
| US-20070034513-A1 | Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array | COMBIMATRIX CORPORATION | 2007-02-15 | — | — | US | claimed |
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | claimed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | claimed |
| WO-2006105037-A2 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | COMBIMATRIX CORPORATION (US) | 2006-10-05 | — | — | WO | claimed |
| US-20060054511-A1 | Electrochemical deblocking using a hydrazine derivative | CUSTOMARRAY, INC. | 2006-03-16 | — | — | US | claimed |
| US-20210395906-A1 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | CUSTOMARRAY INC (US) | 2021-12-23 | — | — | US | disclosed |
| US-10724143-B1 | Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array | CUSTOMARRAY, INC. (US) | 2020-07-28 | — | — | US | disclosed |
| EP-3521485-A1 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | CustomArray,Inc. (US) | 2019-08-07 | — | — | EP | disclosed |
| US-10006131-B1 | Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array | CUSTOMARRAY, INC. (US) | 2018-06-26 | — | — | US | disclosed |
| US-9267213-B1 | Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array | CUSTOMARRAY, INC. (US) | 2016-02-23 | — | — | US | disclosed |
| US-7718579-B2 | Electrochemical deblocking using a hydrazine derivative | COMBIMATRIX CORPORATION (US) | 2010-05-18 | — | — | US | disclosed |
| US-20090253905-A1 | PROCESS FOR THE PREPARATION OF ONIUM SALTS WITH ALKYL- OR ARYLSULFONATE ANIONS OR ALKYL- OR ARYLCARBOXYLATE ANIONS HAVING A LOW HALIDE CONTENT | MERCK PATENT GMBH (DE) | 2009-10-08 | — | — | US | disclosed |
| US-20080039342-A1 | PROCESS FOR TRANSITION METAL-CATALYZED ELECTROCHEMICAL ALLYLIC ALKYLATION ON AN ELECTRODE ARRAY DEVICE | COMBIMATRIX CORPORATION (US) | 2008-02-14 | — | — | US | disclosed |
| US-20070034513-A1 | Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array | COMBIMATRIX CORPORATION | 2007-02-15 | — | — | US | disclosed |
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | disclosed |
| US-20060054511-A1 | Electrochemical deblocking using a hydrazine derivative | CUSTOMARRAY, INC. | 2006-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210395906-A1 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | DNMT1, DNASE1, DNPEP | MEN1 1771/4885HSP90AA1 3933/4885KMT2A 3944/4885 |
| US-20090253905-A1 | PROCESS FOR THE PREPARATION OF ONIUM SALTS WITH ALKYL- OR ARYLSULFONATE ANIONS OR ALKYL- OR ARYLCARBOXYLATE ANIONS HAVING A LOW HALIDE CONTENT | ARSA, STS, SCLY | MEN1 4228/4885HSP90AA1 1426/4885KMT2A 2870/4885 |
| US-10006131-B1 | Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array | DNMT1, DNASE1, DNPEP | MEN1 1771/4885HSP90AA1 3933/4885KMT2A 3944/4885 |
| US-10724143-B1 | Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array | DNMT1, DNASE1, DNPEP | MEN1 1771/4885HSP90AA1 3933/4885KMT2A 3944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.